EUVIMEDEUVIMED entdecken
Crossref

Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Pablo Solís-Muñoz, Ángela Berlana, Elvira del Pozo-Maroto, Lucía Domínguez-Alcón, Liliam Elbouayadi, Carmelo García-Monzón, Águeda González-Rodríguez

Metabolism and Target Organ Damage · 2022

DOI: 10.20517/mtod.2021.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, 2022. Verfasst von Pablo Solís-Muñoz und 6 weiteren Autor:innen. Gefördert von: Becas Gilead Sciences para proyectos de Microeliminaci��n en Hepatitis C, Instituto de Salud Carlos III, Fondo Europeo para el Desarrollo Regional.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is still considered as a major public health problem because in 2015 around 71 million people were chronically infected worldwide. It is important to note that chronic HCV infection is a systemic disease that is associated with diverse extrahepatic disorders including insulin resistance and type 2 diabetes mellitus. The discovery of new direct-acting antiviral agents (DAAs) has become a huge advance in the treatment of HCV infection. The complex interplay between HCV and glucose metabolic pathways remains to be fully elucidated, but it is becoming clearer that elimination of chronic HCV infection halts the progression of liver disease, but more evidence is still needed to better understand how successful antiviral treatment influences insulin resistance and other abnormalities of glucose metabolism linked to HCV infection. This review provides a comprehensive overview of the glucose metabolism disturbances related to chronic HCV infection, highlighting the new insights into the molecular basis of insulin resistance induced by HCV and the mechanisms underlying the reversion of this metabolic disorder by DAAs.

Förderung

  • Becas Gilead Sciences para proyectos de Microeliminaci��n en Hepatitis C
  • Instituto de Salud Carlos III
  • Fondo Europeo para el Desarrollo Regional

Zitieren

APA

Solís-Muñoz, P., Berlana, Á., Pozo-Maroto, E. D., Domínguez-Alcón, L., Elbouayadi, L., García-Monzón, C., & González-Rodríguez, Á. (2022). Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus. Metabolism and Target Organ Damage. https://doi.org/10.20517/mtod.2021.18

Vancouver

Solís-Muñoz P, Berlana Á, Pozo-Maroto ED, Domínguez-Alcón L, Elbouayadi L, García-Monzón C, et al. Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus. Metabolism and Target Organ Damage. 2022. doi:10.20517/mtod.2021.18

BibTeX
@article{SolsMuoz2022,
  author = {Solís-Muñoz, Pablo and Berlana, Ángela and Pozo-Maroto, Elvira del and Domínguez-Alcón, Lucía and Elbouayadi, Liliam and García-Monzón, Carmelo and González-Rodríguez, Águeda},
  title = {Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus},
  journal = {Metabolism and Target Organ Damage},
  year = {2022},
  doi = {10.20517/mtod.2021.18}
}
Kostenlos starten →